These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25837234)

  • 1. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment.
    Petrou P; Vandoros S
    Health Policy; 2015 May; 119(5):563-8. PubMed ID: 25837234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crisis as a serendipity for change in Cyprus' healthcare services.
    Petrou P
    J Med Econ; 2015; 18(10):805-7. PubMed ID: 25958947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective.
    Petrou P
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):627-36. PubMed ID: 24953125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it?
    Petrou P; Vandoros S
    Health Policy; 2018 Feb; 122(2):75-80. PubMed ID: 29274916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving forward: lessons for Cyprus as it implements its health insurance scheme.
    Cylus J; Papanicolas I; Constantinou E; Theodorou M
    Health Policy; 2013 Apr; 110(1):1-5. PubMed ID: 23295160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greek economic crisis and health care reforms: correcting the wrong prescription.
    Niakas D
    Int J Health Serv; 2013; 43(4):597-602. PubMed ID: 24397229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reforms in the Greek pharmaceutical market during the financial crisis.
    Vandoros S; Stargardt T
    Health Policy; 2013 Jan; 109(1):1-6. PubMed ID: 22959163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
    Wouters OJ; Kanavos PG
    Bull World Health Organ; 2015 Sep; 93(9):606-13. PubMed ID: 26478624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2019 introduction of the new National Healthcare System in Cyprus.
    Petrou P
    Health Policy; 2021 Mar; 125(3):284-289. PubMed ID: 33516561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition.
    Jakovljevic MB; Djordjevic N; Jurisevic M; Jankovic S
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):521-30. PubMed ID: 25592856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots' Health: The Memorandum Is Dead, Long Live the Memorandum.
    Petrou P
    Value Health Reg Issues; 2019 Sep; 19():99-103. PubMed ID: 31377656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Kido K; Tsukamoto K
    Int J Health Plann Manage; 2020 Jan; 35(1):e210-e217. PubMed ID: 31710130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health care reform in Portugal: Outcomes from both the New Public Management and the economic crisis.
    Nunes AM; Ferreira DC
    Int J Health Plann Manage; 2019 Jan; 34(1):196-215. PubMed ID: 30109900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyprus health system review.
    Theodorou M; Charalambous C; Petrou C; Cylus J
    Health Syst Transit; 2012; 14(6):1-128. PubMed ID: 23149260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic crisis and counter-reform of universal health care systems: Spanish case.
    Fortes PA; Carvalho RR; Louvison MC
    Rev Saude Publica; 2015; 49():34. PubMed ID: 26083942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region.
    Chen Y; Schweitzer SO
    Value Health; 2008 Mar; 11 Suppl 1():S124-9. PubMed ID: 18387056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuts drive health system reforms in Spain.
    Gallo P; Gené-Badia J
    Health Policy; 2013 Nov; 113(1-2):1-7. PubMed ID: 24035010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health policy making under information constraints: an evaluation of the policy responses to the economic crisis in Greece.
    Goranitis I; Siskou O; Liaropoulos L
    Health Policy; 2014 Sep; 117(3):279-84. PubMed ID: 25150026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating through the maze of pricing and affordability of branded pharmaceuticals in the midst of the financial crisis: a comparative study among five European recession countries, from a Cyprus perspective.
    Petrou P; Talias MA
    J Pharm Policy Pract; 2016; 9():8. PubMed ID: 26981251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Budget for Cyprus' National Health System: The Promised Land or a No Man's Land?
    Petrou P
    Value Health Reg Issues; 2016 Sep; 10():67-72. PubMed ID: 27881280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.